Velacur by Sonic Incytes for Portal Hypertension

计划入组 70 人 · 首次发布于 2020 年 10 月 6 日

The Sonic Incytes Liver Incyte System, Assessment of Liver Fibrosis and Steatosis

计划入组 140 人 · 首次发布于 2019 年 5 月 21 日

The Sonic Incytes Liver Incytes System, Evaluation of Liver Fibrosis and Steatosis Versus MRE and MRI PDFF

计划入组 164 人 · 首次发布于 2020 年 12 月 24 日

Glasdegib(Daurismo)

C₂₁H₂₂N₆O

HPK1 inhibitors(Incyte)

CDK2 inhibitor(Incyte)

SONIA ANAND

India

Incyte

United States

Incyte Corporation

United States

FDA Clears Sonic Incytes' AI-Guided Velacur ONE Ultrasound Device for Chronic Liver Disease Management

Sonic Incytes' Velacur VDFF Receives FDA 510(k) Clearance for Enhanced Liver Fat Assessment

Santen and Singapore Eye Research Institute Launch $21 Million Collaboration to Develop Disease-Modifying Eye Therapies